STAT

APRIL 14, 2024

As diligent taxpayers breathe a sigh of relief that the hassle of filing their tax forms is over for another year, the Internal Revenue Service continues to let most U.S. hospitals pay nothing in federal taxes. It’s time for Congress to take a hard look at the IRS’s hand in health care. The agency uses a vague “community benefit” standard to liberally grant tax-exempt status to so-called nonprofit hospitals even as many of them are financially taking advantage of sick

Hospitals 364

Hospitals 364

ID Stewardship

APRIL 14, 2024

In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., PharmD, BCPS, BCIDP, AAHIV-M Disclaimer : This text and table is intended for use as a study tool to assist people learning pharmacotherapy of recurrent Clostridioides difficile infections (rCDI).

Hospitals 129

Hospitals Communication 129

Express Pharma

APRIL 14, 2024

The FDA has approved Basilea Pharmaceutica’s advanced generation cephalosporin antibiotic, Zevtera (ceftobiprole medocaril), for the treatment of three major indications: Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP).

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies 92

pharmaphorum

APRIL 14, 2024

EMA review finds no link between GLP-1 agonists used to treat diabetes and obesity and thoughts of suicide or self-injury.

Diabetes 109

Diabetes 109

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

APRIL 14, 2024

Granules India’s Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India has successfully completed the US Food and Drug Administration (FDA) inspection between April 8-12 2024, resulting in zero 483 observations. This audit was a Pre-Approval Inspection (PAI) and cGMP audit for Active Pharmaceutical Ingredients (APIs) and Formulations (FDs) for oncology and non-oncology products.

78

78

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.

59

59

Drug Patent Watch

APRIL 14, 2024

DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 8,722,084 Expiration: Apr 15, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.

59

59

Pharmacy Joe

APRIL 14, 2024

In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease. Episode 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? Subscribe on iTunes , Android , or Stitcher The prescribing information for apixaban recommends not reducing the dose when being used in patients with end-stage renal disease and atrial fibrillation.

Inpatient 52

Inpatient Dosage 52

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers.

59

59

Pharmacy Times

APRIL 14, 2024

Pandemic-related growing pains were common within health care, bringing unique challenges for health systems.

58

58

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from four suppliers.

59

59

The Guardian - Pharmaceutical Industry

APRIL 14, 2024

Exclusive: contaminated blood campaigners say internal 1976 Immuno AG document proves British government negligence Analysis: families hope report will finally apportion blame The British government was willing to risk infecting NHS patients to get “lower-priced” blood products, according to a document that campaigners claim proves state and corporate guilt in one of the country’s worst ever scandals.

Documentation 134

Documentation 134

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from five suppliers.

59

59

PharmaState Academy

APRIL 14, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for TAGRISSO Tagrisso is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier.

59

59

PharmaState Academy

APRIL 14, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

Drug Patent Watch

APRIL 14, 2024

Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier.

59

59

PharmaState Academy

APRIL 14, 2024

Get set for your success in GPAT journey with the Mock Test-14. Take Part Right Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time.

52

52

Drug Patent Watch

APRIL 14, 2024

This chart shows the pharmaceutical companies with the most patents in New Zealand.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52